Philip S. Bernard

Determination of drug sensitivity in patient derived models of breast cancer by multiparametric quantitative phase imaging

Functional precision oncology aims to guide therapy selection by directly measuring drug sensitivity in patient-derived cancer samples. However, most existing functional assays require prolonged cell expansion limiting their feasibility for time-sensitive clinical decision-making. We evaluated whether multiparame...